molecular pathology Search Results


90
STRATIFYER Molecular Pathology GmbH xtrakt kit
Xtrakt Kit, supplied by STRATIFYER Molecular Pathology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/xtrakt+kit/pmc06198219-209-29-31
Average 90 stars, based on 1 article reviews
xtrakt kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Huntsman International LLC biorepository and molecular pathology
Biorepository And Molecular Pathology, supplied by Huntsman International LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/biorepository+and+molecular+pathology+shared+resource/pmc06197489-990-20-9
Average 90 stars, based on 1 article reviews
biorepository and molecular pathology - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
College of American Pathologists cap checklist for molecular pathology
Cap Checklist For Molecular Pathology, supplied by College of American Pathologists, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/molecular+pathology+checklist/pm12709360-5-44-36
Average 90 stars, based on 1 article reviews
cap checklist for molecular pathology - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Targos Molecular Pathology targos-a discovery life
Targos A Discovery Life, supplied by Targos Molecular Pathology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/targos+a+discovery+life/pm38397199-396-11-11
Average 90 stars, based on 1 article reviews
targos-a discovery life - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Targos Molecular Pathology her2 screening
<t> HER2 </t> testing results from the screening phase of the study, according to immunohistochemistry and fluorescence in situ hybridization
Her2 Screening, supplied by Targos Molecular Pathology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/her2+testing/pmc04511072-134-0-13
Average 90 stars, based on 1 article reviews
her2 screening - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
STRATIFYER Molecular Pathology GmbH taqman gene expression assays mp015
<t> HER2 </t> testing results from the screening phase of the study, according to immunohistochemistry and fluorescence in situ hybridization
Taqman Gene Expression Assays Mp015, supplied by STRATIFYER Molecular Pathology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/taqman+gene+expression+assays+mp015/pmc09323197-169-51-62
Average 90 stars, based on 1 article reviews
taqman gene expression assays mp015 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ludwig Boltzmann Gesellschaft molecular pathology
<t> HER2 </t> testing results from the screening phase of the study, according to immunohistochemistry and fluorescence in situ hybridization
Molecular Pathology, supplied by Ludwig Boltzmann Gesellschaft, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/molecular+pathology/10__1016_slash_j__annonc__2020__08__591-84-11-15
Average 90 stars, based on 1 article reviews
molecular pathology - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Myriad Genetics supreme court’s decision in association for molecular pathology v. myriad genetics
<t> HER2 </t> testing results from the screening phase of the study, according to immunohistochemistry and fluorescence in situ hybridization
Supreme Court’s Decision In Association For Molecular Pathology V. Myriad Genetics, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/ass%E2%80%99n+for+molecular+pathology+v++myriad+genetics/10__1111_slash_coep__12189-286-15-24
Average 90 stars, based on 1 article reviews
supreme court’s decision in association for molecular pathology v. myriad genetics - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
STRATIFYER Molecular Pathology GmbH xtrakt ffpe kit

Xtrakt Ffpe Kit, supplied by STRATIFYER Molecular Pathology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/xtrakt+ffpe+kit/pmc10405067-29-0-4
Average 90 stars, based on 1 article reviews
xtrakt ffpe kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
STRATIFYER Molecular Pathology GmbH xtrakt sl

Xtrakt Sl, supplied by STRATIFYER Molecular Pathology GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/xtrakt+sl/pmc04255018-67-38-43
Average 90 stars, based on 1 article reviews
xtrakt sl - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Canterbury Health Laboratories microbiology unit

Microbiology Unit, supplied by Canterbury Health Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/molecular+pathology/pm24311761-68-20-23
Average 90 stars, based on 1 article reviews
microbiology unit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Targos Molecular Pathology tissue microarray

Tissue Microarray, supplied by Targos Molecular Pathology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+pathology/tissue+microarray/pm29946185-397-1-12
Average 90 stars, based on 1 article reviews
tissue microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


 HER2  testing results from the screening phase of the study, according to immunohistochemistry and fluorescence in situ hybridization

Journal: Gastric Cancer

Article Title: HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

doi: 10.1007/s10120-014-0402-y

Figure Lengend Snippet: HER2 testing results from the screening phase of the study, according to immunohistochemistry and fluorescence in situ hybridization

Article Snippet: HER2 screening in the ToGA study was performed in a central testing laboratory (Targos Molecular Pathology GmbH); it is anticipated that HER2-positivity rates may vary when HER2 testing data are reported from regional centers, further highlighting the need for standardized HER2 testing and scoring and the use of accurate and validated assays [ ].

Techniques: Immunohistochemistry, Fluorescence, In Situ

 HER2  testing results in patients potentially eligible for enrollment into ToGA, according to immunohistochemistry and fluorescence in situ hybridization

Journal: Gastric Cancer

Article Title: HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

doi: 10.1007/s10120-014-0402-y

Figure Lengend Snippet: HER2 testing results in patients potentially eligible for enrollment into ToGA, according to immunohistochemistry and fluorescence in situ hybridization

Article Snippet: HER2 screening in the ToGA study was performed in a central testing laboratory (Targos Molecular Pathology GmbH); it is anticipated that HER2-positivity rates may vary when HER2 testing data are reported from regional centers, further highlighting the need for standardized HER2 testing and scoring and the use of accurate and validated assays [ ].

Techniques: Immunohistochemistry, Fluorescence, In Situ

Proportion of tumors that tested positive for HER2 based on data from all patients screened and from patients successfully screened by immunohistochemistry or fluorescence in situ hybridization, according to patient demographics and tumor characteristics

Journal: Gastric Cancer

Article Title: HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

doi: 10.1007/s10120-014-0402-y

Figure Lengend Snippet: Proportion of tumors that tested positive for HER2 based on data from all patients screened and from patients successfully screened by immunohistochemistry or fluorescence in situ hybridization, according to patient demographics and tumor characteristics

Article Snippet: HER2 screening in the ToGA study was performed in a central testing laboratory (Targos Molecular Pathology GmbH); it is anticipated that HER2-positivity rates may vary when HER2 testing data are reported from regional centers, further highlighting the need for standardized HER2 testing and scoring and the use of accurate and validated assays [ ].

Techniques: Immunohistochemistry, Fluorescence, In Situ Hybridization

Proportion of patients with tumor  HER2  staining variability (≤30 % stained cells) by IHC category

Journal: Gastric Cancer

Article Title: HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

doi: 10.1007/s10120-014-0402-y

Figure Lengend Snippet: Proportion of patients with tumor HER2 staining variability (≤30 % stained cells) by IHC category

Article Snippet: HER2 screening in the ToGA study was performed in a central testing laboratory (Targos Molecular Pathology GmbH); it is anticipated that HER2-positivity rates may vary when HER2 testing data are reported from regional centers, further highlighting the need for standardized HER2 testing and scoring and the use of accurate and validated assays [ ].

Techniques: Staining

Efficacy of trastuzumab plus chemotherapy vs. chemotherapy alone according to  HER2  expression status (screened by immunohistochemistry or fluorescence in situ hybridization)

Journal: Gastric Cancer

Article Title: HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

doi: 10.1007/s10120-014-0402-y

Figure Lengend Snippet: Efficacy of trastuzumab plus chemotherapy vs. chemotherapy alone according to HER2 expression status (screened by immunohistochemistry or fluorescence in situ hybridization)

Article Snippet: HER2 screening in the ToGA study was performed in a central testing laboratory (Targos Molecular Pathology GmbH); it is anticipated that HER2-positivity rates may vary when HER2 testing data are reported from regional centers, further highlighting the need for standardized HER2 testing and scoring and the use of accurate and validated assays [ ].

Techniques: Expressing, Immunohistochemistry, Fluorescence, In Situ Hybridization

Journal: iScience

Article Title: Reinvestigating the clinical relevance of the m 6 A writer METTL3 in urothelial carcinoma of the bladder

doi: 10.1016/j.isci.2023.107300

Figure Lengend Snippet:

Article Snippet: XTRAKT FFPE kit , Stratifyer , Cat#XTK2.0-96.

Techniques: Western Blot, Expressing, Real-time Polymerase Chain Reaction, Recombinant, Cell Viability Assay, Caspase-Glo Assay, Purification, CRISPR, Software